ATE344039T1 - Nicht-calcemische, transkriptionell-aktive, schwefelhaltige analoga von 1-alpha, 25- dihydroxyvitamin d3 mit antiproliferativer wirkung - Google Patents
Nicht-calcemische, transkriptionell-aktive, schwefelhaltige analoga von 1-alpha, 25- dihydroxyvitamin d3 mit antiproliferativer wirkungInfo
- Publication number
- ATE344039T1 ATE344039T1 AT00921523T AT00921523T ATE344039T1 AT E344039 T1 ATE344039 T1 AT E344039T1 AT 00921523 T AT00921523 T AT 00921523T AT 00921523 T AT00921523 T AT 00921523T AT E344039 T1 ATE344039 T1 AT E344039T1
- Authority
- AT
- Austria
- Prior art keywords
- dihydroxyvitamin
- calcemic
- alpha
- sulfur containing
- transcriptionally active
- Prior art date
Links
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 title abstract 2
- 230000001028 anti-proliverative effect Effects 0.000 title abstract 2
- 229910052717 sulfur Inorganic materials 0.000 title abstract 2
- 239000011593 sulfur Substances 0.000 title abstract 2
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical class C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 title 1
- 230000000125 calcaemic effect Effects 0.000 abstract 1
- 229960005084 calcitriol Drugs 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000002103 transcriptional effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12732899P | 1999-04-01 | 1999-04-01 | |
| US12847899P | 1999-04-09 | 1999-04-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE344039T1 true ATE344039T1 (de) | 2006-11-15 |
Family
ID=26825543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00921523T ATE344039T1 (de) | 1999-04-01 | 2000-03-31 | Nicht-calcemische, transkriptionell-aktive, schwefelhaltige analoga von 1-alpha, 25- dihydroxyvitamin d3 mit antiproliferativer wirkung |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6380408B1 (de) |
| EP (2) | EP1180035B1 (de) |
| JP (2) | JP3630101B2 (de) |
| AT (1) | ATE344039T1 (de) |
| CA (1) | CA2366586C (de) |
| CY (1) | CY1107548T1 (de) |
| DE (1) | DE60031666T2 (de) |
| DK (1) | DK1180035T3 (de) |
| ES (2) | ES2274785T3 (de) |
| HK (1) | HK1044293B (de) |
| MX (1) | MXPA01009693A (de) |
| PT (1) | PT1180035E (de) |
| WO (1) | WO2000059513A1 (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE428692T1 (de) * | 2001-08-22 | 2009-05-15 | Univ Johns Hopkins | 24-schwefel-substituierte 1-alpha-25-dihydroxy- vitamin-d3-analogen |
| US6559138B1 (en) * | 2001-09-21 | 2003-05-06 | Syntex (U.S.A.) Llc | 3-Desoxy-vitamin D3 analog esters |
| US7101865B2 (en) | 2002-06-13 | 2006-09-05 | Cytochroma Inc. | 24-sulfoximine vitamin D3 compounds |
| CA2510228C (en) * | 2002-12-18 | 2012-10-30 | Johns Hopkins University | 25-so2-substituted analogs of 1.alpha.,25-dihydroxyvitamin d3 |
| CA2544502A1 (en) * | 2003-11-25 | 2005-06-09 | Wisconsin Alumni Research Foundation | Vitamin d analogs for obesity prevention and treatment |
| WO2006074227A2 (en) * | 2005-01-04 | 2006-07-13 | Johns Hopkins University | HIGHLY ANTIPROLIFERATIVE, LOW-CALCEMIC, ANALOGS OF THE HORMONE 1α, 25-DIHYDROXYVITAMIN D3 WITH CARBONYL SIDE CHAINS |
| US20090137828A1 (en) * | 2005-08-18 | 2009-05-28 | Bioxell S.P.A. | Synthesis of 1A-Fluoro-25-Hydroxy-16-23E-Diene-26,27-Bishomo-20-Epi-Cholecalciferol |
| US20070122477A1 (en) * | 2005-10-12 | 2007-05-31 | Cytochroma, Inc. | Methods and articles for treating 25-hydroxyvitamin D insufficiency and deficiency |
| PT3095447T (pt) | 2006-02-03 | 2022-01-24 | Opko Renal Llc | Tratamento da insuficiência e deficiência de vitamina d com 25-hidroxivitamina d2 e 25-hidroxivitamina d3 |
| DK2037936T3 (da) | 2006-06-21 | 2014-09-22 | Opko Renal Llc | Fremgangsmåde til behandling og forebyggelse af sekundær hyperparathyroidisme |
| WO2008131267A2 (en) * | 2007-04-18 | 2008-10-30 | Johns Hopkins University | Low calcemic, highly antiproliferative, analogs of calcitriol |
| ES3047207T3 (en) | 2007-04-25 | 2025-12-03 | Opko Renal Llc | Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease |
| CA2683628C (en) * | 2007-04-25 | 2018-03-06 | Cytochroma Inc. | Method of treating vitamin d insufficiency and deficiency |
| EP2148685A4 (de) * | 2007-04-25 | 2010-07-28 | Cytochroma Inc | Verfahren und verbindungen für die vitamin-d-therapie |
| KR101691876B1 (ko) | 2007-04-25 | 2017-01-02 | 사이토크로마 인코포레이티드 | 비타민 d 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물 |
| ES2593356T3 (es) | 2008-04-02 | 2016-12-07 | Opko Ireland Global Holdings, Ltd. | Métodos, composiciones, usos y kits útiles para la deficiencia de la vitamina D y trastornos relacionados |
| WO2011088209A2 (en) * | 2010-01-13 | 2011-07-21 | Cytochroma Inc. | 1-deoxy analogs of vitamin d-related compounds |
| WO2011119610A2 (en) | 2010-03-23 | 2011-09-29 | Wisconsin Alumni Research Foundation | (20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1α,25- DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22- DIMETHYL-1α,25-HYDROXYVITAMIN D3 |
| US8664206B2 (en) | 2010-03-23 | 2014-03-04 | Wisconsin Alumni Research Foundation | Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3 |
| US11672809B2 (en) | 2010-03-29 | 2023-06-13 | Eirgen Pharma Ltd. | Methods and compositions for reducing parathyroid levels |
| US8788551B2 (en) | 2011-11-15 | 2014-07-22 | Seagate Technology Llc | Random number generation using switching regulators |
| US9201630B2 (en) | 2012-02-10 | 2015-12-01 | Seagate Technology Llc | Random number generation using startup variances |
| KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 d 방출 제형 |
| US10220047B2 (en) | 2014-08-07 | 2019-03-05 | Opko Ireland Global Holdings, Ltd. | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor |
| KR20180123100A (ko) | 2016-03-28 | 2018-11-14 | 옵코 아일랜드 글로벌 홀딩스 리미티드 | 비타민 d 치료 방법 |
| WO2025094144A1 (en) | 2023-11-02 | 2025-05-08 | Eirgen Pharma Ltd. | Controlling loss of kidney function |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5119752A (en) | 1974-08-07 | 1976-02-17 | Masayuki Ishikawa | 1 arufua* 2 arufuaa jihidorokishikorekarushifuerooruno seiho |
| US4224231A (en) | 1979-09-04 | 1980-09-23 | Wisconsin Alumni Research Foundation | Derivatives of 25-hydroxycholecalciferol |
| US4927815A (en) * | 1988-04-29 | 1990-05-22 | Wisconsin Alumni Research Foundation | Compounds effective in inducing cell differentiation and process for preparing same |
| JPH0667898B2 (ja) * | 1989-02-15 | 1994-08-31 | 大同ほくさん株式会社 | 22,23―セコビタミンd若しくはその活性型またはそれらの誘導体の製造方法 |
| US5401732A (en) | 1989-02-23 | 1995-03-28 | Leo Pharmaceutical Products Ltd. A/S Kemiske Fabrik Produkionsaktiese Skab | Vitamin D analogues |
| US4973584A (en) * | 1989-03-09 | 1990-11-27 | Deluca Hector F | Novel 1α-hydroxyvitamin D2 epimer and derivatives |
| US5401731A (en) | 1989-06-29 | 1995-03-28 | Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Productionsaktieselskab) | Vitamin D analogues |
| GB8915770D0 (en) | 1989-07-10 | 1989-08-31 | Leo Pharm Prod Ltd | Chemical compounds |
| US5260290A (en) | 1990-02-14 | 1993-11-09 | Wisconsin Alumni Research Foundation | Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives |
| GB9007236D0 (en) * | 1990-03-30 | 1990-05-30 | Leo Pharm Prod Ltd | Chemical compounds |
| GB9015774D0 (en) | 1990-07-18 | 1990-09-05 | Leo Pharm Prod Ltd | Novel treatment |
| US5830885A (en) | 1992-03-12 | 1998-11-03 | The Johns Hopkins University | Antiproliferative vitamin D3 hybrids |
| US5274142A (en) | 1992-03-12 | 1993-12-28 | The Johns Hopkins University | Vitamin D3 analogues |
| US5403832A (en) | 1992-03-12 | 1995-04-04 | The Johns Hopkins University | Vitamin D3 analogues |
| GB9226877D0 (en) | 1992-12-23 | 1993-02-17 | Leo Pharm Prod Ltd | Chemical compounds |
| US6043386A (en) | 1998-06-03 | 2000-03-28 | John Hopkins University | Non-calcemic, antiproliferative, transcriptionally active 24-fluorinated hybrid analogs of 1α,-25-dihydroxy vitamin D3 |
-
2000
- 2000-03-31 ES ES00921523T patent/ES2274785T3/es not_active Expired - Lifetime
- 2000-03-31 MX MXPA01009693A patent/MXPA01009693A/es active IP Right Grant
- 2000-03-31 HK HK02106019.2A patent/HK1044293B/en not_active IP Right Cessation
- 2000-03-31 WO PCT/US2000/008462 patent/WO2000059513A1/en not_active Ceased
- 2000-03-31 AT AT00921523T patent/ATE344039T1/de active
- 2000-03-31 US US09/541,060 patent/US6380408B1/en not_active Expired - Lifetime
- 2000-03-31 DE DE60031666T patent/DE60031666T2/de not_active Expired - Lifetime
- 2000-03-31 EP EP00921523A patent/EP1180035B1/de not_active Expired - Lifetime
- 2000-03-31 CA CA002366586A patent/CA2366586C/en not_active Expired - Lifetime
- 2000-03-31 JP JP2000609076A patent/JP3630101B2/ja not_active Expired - Fee Related
- 2000-03-31 PT PT00921523T patent/PT1180035E/pt unknown
- 2000-03-31 ES ES06020197.7T patent/ES2614632T3/es not_active Expired - Lifetime
- 2000-03-31 EP EP06020197.7A patent/EP1745787B1/de not_active Expired - Lifetime
- 2000-03-31 DK DK00921523T patent/DK1180035T3/da active
-
2004
- 2004-10-01 JP JP2004289968A patent/JP3796508B2/ja not_active Expired - Fee Related
-
2007
- 2007-01-29 CY CY20071100119T patent/CY1107548T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1180035A4 (de) | 2003-07-30 |
| MXPA01009693A (es) | 2002-03-14 |
| CA2366586A1 (en) | 2000-10-12 |
| CA2366586C (en) | 2004-06-22 |
| JP3630101B2 (ja) | 2005-03-16 |
| JP2002541112A (ja) | 2002-12-03 |
| JP3796508B2 (ja) | 2006-07-12 |
| DE60031666T2 (de) | 2007-08-30 |
| US6380408B1 (en) | 2002-04-30 |
| ES2274785T3 (es) | 2007-06-01 |
| DE60031666D1 (de) | 2006-12-14 |
| EP1745787A3 (de) | 2007-02-07 |
| CY1107548T1 (el) | 2013-03-13 |
| EP1180035A1 (de) | 2002-02-20 |
| EP1745787B1 (de) | 2016-11-09 |
| JP2005023087A (ja) | 2005-01-27 |
| DK1180035T3 (da) | 2007-03-05 |
| WO2000059513A1 (en) | 2000-10-12 |
| EP1180035B1 (de) | 2006-11-02 |
| PT1180035E (pt) | 2007-02-28 |
| EP1745787A2 (de) | 2007-01-24 |
| HK1044293B (en) | 2007-06-08 |
| HK1044293A1 (en) | 2002-10-18 |
| ES2614632T3 (es) | 2017-06-01 |
| WO2000059513A8 (en) | 2001-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60031666D1 (de) | NICHT-CALCEMISCHE, TRANSKRIPTIONELL-AKTIVE, SCHWEFELHALTIGE ANALOGA VON 1-alpha, 25-DIHYDROXYVITAMIN D3 MIT ANTIPROLIFERATIVER WIRKUNG | |
| DE60016670D1 (de) | Kosmetisches Mittel enthaltend mindestens einen Hydroxystilben und Ascorbinsäure | |
| ATE33503T1 (de) | Pharmazeutische und tiermedizinische praeparate von interleukin-2, in dem cystein-125 ausgetauscht worden ist (muteine), sowie deren herstellung. | |
| PT2455083E (pt) | Composição farmacêutica para aplicação dérmica compreendendo calcipotriol e betametasona para o tratamento da psoríase | |
| ATE396966T1 (de) | Carbocyclische und oxacarbocyclische fumarsaeure- oligomere | |
| CY1109341T1 (el) | Διαμορφωτες υποδοχεα βιταμινης d τυπου φαινυλο-θειοφαινιου | |
| ES245929U (es) | Dispositivo para el montaje elastico y soporte de una super-estructura dental | |
| ES2136105T3 (es) | Preparacion farmaceutica y/o cosmetica. | |
| NL163713C (nl) | Samenstel van gebitsprothese en ten minste een samenwerkend implantaat. | |
| ZA945427B (en) | Side chain-modified 1alpha-hydroxy vitamin D analogues | |
| ATE155485T1 (de) | Bpc-peptide, ihre herstellung und verwendung | |
| LT2004074A (en) | Matricines metalproteinazes inhibuojanti kompozicija neoplazinems ligoms gydyti | |
| DK1565422T3 (da) | Vitamin-D-receptor-modulatorer | |
| NO882453L (no) | T-pa-analog. | |
| ES2131863T3 (es) | Derivados de colchicina y su uso terapeutico. | |
| JPS6485079A (en) | Tissue plasminogen activating factor analog having improved proliferating factor domain | |
| ATE239700T1 (de) | 24,24-difluorierte analogen von 1-alpha,25- dihydroxy vitamin d3 | |
| EP0212912A3 (de) | Calcitonin-Analoga mit C-terminalen D-Aminosäurensubstituenten | |
| DK0415902T3 (da) | Oxy- eller thiosubstituerede fedtsyreanaloger til anvendelse ved behandling af retrovirale infektioner | |
| ES2038729T3 (es) | Producto insecticida. | |
| IT1283684B1 (it) | Calzatura con struttura di sostegno e irrigidimento e procedimento per realizzare tale calzatura | |
| DE59814311D1 (de) | Calicitonin-Analoga mit stark erhöhter hypocalcämischer Wirkung in vivo | |
| GB2000783A (en) | Physiologically active enkephalin analogues | |
| YU2394A (sh) | Lizin so 6-hloro-5-fluoro-3-(-2-tenoil)-2-oksindol-1-karboksamida | |
| EP0351017A3 (en) | Pharmaceutical composition useful for the treatment of cardiovascular diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1180035 Country of ref document: EP |